Ⓐ
PeptiBrief
Human metabolic physiology study· 2012

Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes

Wice BM|Reeds DN|Tran HD|Crimmins DL|Patterson BW|Dunai J|Wallendorf MJ|Ladenson JH|Villareal DT|Polonsky KS

Diabetes

PubMed
22522617
Evidence level
moderate
Verification
verified

Summary

The study tested whether xenin-25 augments GIP-mediated glucose-stimulated insulin secretion in different glucose-tolerance groups.

Limitations

Small physiology study|Short infusion|No long-term metabolic outcomes

Linked peptides

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.